|
1
|
Brindley PJ, Bachini M, Ilyas SI, Khan SA,
Loukas A, Sirica AE, Teh BT, Wongkham S and Gores GJ:
Cholangiocarcinoma. Nat Rev Dis Primers. 7:652021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Banales JM, Marin JJG, Lamarca A,
Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen
JB, Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in
mechanisms and management. Nat Rev Gastroenterol Hepatol.
17:557–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Krasinskas AM: Cholangiocarcinoma. Surg
Pathol Clin. 11:403–429. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khan AS and Dageforde LA:
Cholangiocarcinoma. Surg Clin North Am. 99:315–335. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deoliveira ML, Cunningham SC, Cameron JL,
Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick
RD: Cholangiocarcinoma: Thirty-one-year experience with 564
patients at a single institution. Ann Surg. 245:755–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Groot Koerkamp B, Wiggers JK, Gonen M,
Doussot A, Allen PJ, Besselink MG, Blumgart LH, Busch OR,
D'angelica MI, DeMatteo RP, et al: Survival after resection of
perihilar cholangiocarcinoma-development and external validation of
a prognostic nomogram. Ann Oncol. 27:7532016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ghaleb AM and Yang VW: Krüppel-like factor
4 (KLF4): What we currently know. Gene. 611:27–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo X, Zhang Y, Meng Y, Ji M and Wang Y:
Prognostic significance of KLF4 in solid tumours: An updated
meta-analysis. BMC Cancer. 22:1812022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang N, Liu ZH, Ding F, Wang XQ, Zhou CN
and Wu M: Down-regulation of gut-enriched Kruppel-like factor
expression in esophageal cancer. World J Gastroenterol. 8:966–970.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei D, Kanai M, Huang S and Xie K:
Emerging role of KLF4 in human gastrointestinal cancer.
Carcinogenesis. 27:23–31. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao W, Hisamuddin IM, Nandan MO, Babbin
BA, Lamb NE and Yang VW: Identification of Krüppel-like factor 4 as
a potential tumor suppressor gene in colorectal cancer. Oncogene.
23:395–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ohnishi S, Ohnami S, Laub F, Aoki K,
Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F and Yoshida T:
Downregulation and growth inhibitory effect of epithelial-type
Krüppel-like transcription factor KLF4, but not KLF5, in bladder
cancer. Biochem Biophys Res Commun. 308:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pandya AY, Talley LI, Frost AR, Fitzgerald
TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA,
Krontiras H, et al: Nuclear localization of KLF4 is associated with
an aggressive phenotype in early-stage breast cancer. Clin Cancer
Res. 10:2709–2719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Z, Zhang Y, Chen X, Wu P and Chen D:
Long non-coding RNA LINC00673 silencing inhibits proliferation and
drug resistance of prostate cancer cells via decreasing KLF4
promoter methylation. J Cell Mol Med. 24:1878–1892. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao C, Li Y, Qiu W, He F, Zhang W, Zhao
D, Zhang Z, Zhang E, Ma P, Liu Y, et al: C5a induces A549 cell
proliferation of non-small cell lung cancer via GDF15 gene
activation mediated by GCN5-dependent KLF5 acetylation. Oncogene.
37:4821–4837. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li S, Ma YM, Zheng PS and Zhang P: GDF15
promotes the proliferation of cervical cancer cells by
phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J Exp
Clin Cancer Res. 37:802018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Q, Xu HX, Li JP, Wang S, Fu Z, Jia J,
Wang L, Zhu ZF, Lu R and Yao Z: Growth differentiation factor 15
induces growth and metastasis of human liver cancer stem-like cells
via AKT/GSK-3β/β-catenin signaling. Oncotarget. 8:16972–16987.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin Y, Jung SN, Lim MA, Oh C, Piao Y, Kim
HJ, Liu L, Kang YE, Chang JW, Won HR, et al: Transcriptional
regulation of GDF15 by EGR1 promotes head and neck cancer
progression through a positive feedback loop. Int J Mol Sci.
22:111512021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong G, Huang X, Jiang S, Ni L, Ma L, Zhu
C and Chen S: SCAP mediated GDF15-induced invasion and EMT of
esophageal cancer. Front Oncol. 10:5647852020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joshi JP, Brown NE, Griner SE and Nahta R:
Growth differentiation factor 15 (GDF15)-mediated HER2
phosphorylation reduces trastuzumab sensitivity of
HER2-overexpressing breast cancer cells. Biochem Pharmacol.
82:1090–1099. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang M, Narita S, Koizumi A, Nara T,
Numakura K, Satoh S, Nanjo H and Habuchi T: Macrophage inhibitory
cytokine-1 induced by a high-fat diet promotes prostate cancer
progression by stimulating tumor-promoting cytokine production from
tumor stromal cells. Cancer Commun (Lond). 41:389–403. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan Y, Yue X, Yang S, Zhao Z, Wu P and Liu
H: The expression of growth differentiation factor 15 in
gallbladder carcinoma. J BUON. 26:218–228. 2021.PubMed/NCBI
|
|
24
|
Li C, Wang J, Kong J, Tang J, Wu Y, Xu E,
Zhang H and Lai M: GDF15 promotes EMT and metastasis in colorectal
cancer. Oncotarget. 7:860–872. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Baek SJ and Eling TE: The diverse
roles of nonsteroidal anti-inflammatory drug activated gene
(NAG-1/GDF15) in cancer. Biochem Pharmacol. 85:597–606. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang L, Li F and Gu C: GDF-15: A
multifunctional modulator and potential therapeutic target in
cancer. Curr Pharm Des. 25:654–662. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Goldstein BG, Chao HH and Katz JP:
KLF4 and KLF5 regulate proliferation, apoptosis and invasion in
esophageal cancer cells. Cancer Biol Ther. 4:1216–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li JC, Chen QH, Jian R, Zhou JR, Xu Y, Lu
F, Li JQ and Zhang H: The partial role of KLF4 and KLF5 in
gastrointestinal tumors. Gastroenterol Res Pract. 2021:24253562021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang XM, Liu ZL, Qiu B, Xu YF, Pan C and
Zhang ZL: Downregulation of EVI1 expression inhibits cell
proliferation and induces apoptosis in hilar cholangiocarcinoma via
the PTEN/AKT signalling pathway. J Cancer. 11:1412–1423. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo K, Cui J, Quan M, Xie D, Jia Z, Wei D,
Wang L, Gao Y, Ma Q and Xie K: The novel KLF4/MSI2 signaling
pathway regulates growth and metastasis of pancreatic cancer. Clin
Cancer Res. 23:687–696. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rowland BD, Bernards R and Peeper DS: The
KLF4 tumour suppressor is a transcriptional repressor of p53 that
acts as a context-dependent oncogene. Nat Cell Biol. 7:1074–1082.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu W, Hofstetter WL, Li H, Zhou Y, He Y,
Pataer A, Wang L, Xie K, Swisher SG and Fang B: Putative
tumor-suppressive function of Kruppel-like factor 4 in primary lung
carcinoma. Clin Cancer Res. 15:5688–5695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Patel NV, Ghaleb AM, Nandan MO and Yang
VW: Expression of the tumor suppressor Krüppel-like factor 4 as a
prognostic predictor for colon cancer. Cancer Epidemiol Biomarkers
Prev. 19:2631–2638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen YJ, Wu CY, Chang CC, Ma CJ, Li MC and
Chen CM: Nuclear Krüppel-like factor 4 expression is associated
with human skin squamous cell carcinoma progression and metastasis.
Cancer Biol Ther. 7:777–782. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu W, Jia Y, Xiao X, Lv K, Chen Y, Wang L,
Luo X, Liu T, Li W, Li Y, et al: KLF4 downregulates hTERT
expression and telomerase activity to inhibit lung carcinoma
growth. Oncotarget. 7:52870–52887. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rowland BD and Peeper DS: KLF4, p21 and
context-dependent opposing forces in cancer. Nat Rev Cancer.
6:11–23. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ghaleb AM, McConnell BB, Kaestner KH and
Yang VW: Altered intestinal epithelial homeostasis in mice with
intestine-specific deletion of the Krüppel-like factor 4 gene. Dev
Biol. 349:310–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cui J, Shi M, Quan M and Xie K: Regulation
of EMT by KLF4 in gastrointestinal cancer. Curr Cancer Drug
Targets. 13:986–999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Modi A, Purohit P, Roy D, Vishnoi JR,
Pareek P, Elhence P, Singh P, Sharma S, Sharma P and Misra S: FOXM1
mediates GDF-15 dependent stemness and intrinsic drug resistance in
breast cancer. Mol Biol Rep. 49:2877–2888. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
